(Q35127391)

6 August 2017

1 reference

title

Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm (English)

1 reference

6 August 2017

Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm (English)

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

author name string

Bramah N. Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746748

2 January 2024

language of work or name

1 reference

1 June 2003

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

6 August 2017

published in

1 reference

6 August 2017

volume

8 Suppl 1

1 reference

6 August 2017

page(s)

S13-26

1 reference

Evolution of diagnostic and interventional cardiac electrophysiology: a brief historical review

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Epidemiology and significance of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Pathology of atrial fibrillation in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

The natural history of lone atrial fibrillation. A population-based study over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Secular trends in the prevalence of atrial fibrillation: The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

A population-based study of mortality among patients with atrial fibrillation or flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Does atrial fibrillation confer a hypercoagulable state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Rate-dependence of antiarrhythmic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Comparative mechanisms of action of antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

The azimilide post-infarct survival evaluation (ALIVE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800103

Atrial fibrillation and congestive heart failure: the intersection of two common diseases

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Atrial fibrillation: a growth industry in the 21st century

2 January 2024

8

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

2 January 2024

17

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Dialogues in cardiovascular medicine : DCM

2 January 2024

19

6

67

2001

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Atrial fibrillation: an old disease, a new epidemic

2 January 2024

23

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Journal of the American College of Cardiology

2 January 2024

26

39

61B

2002

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Epidemiological and mechanistic studies of atrial fibrillation as a basis for treatment strategies

2 January 2024

29

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

2 January 2024

30

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm

2 January 2024

37

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

38

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

The New England Journal of Medicine

2 January 2024

39

34

910

1999

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Dialogues in cardiovascular medicine : DCM

2 January 2024

42

6

95

2001

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Dialogues in cardiovascular medicine : DCM

2 January 2024

43

6

112

2001

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

Pharmacological Reviews

57

30

5

1979

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

2 January 2024

60

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Frequency-dependent electrophysiologic effects of amiodarone in humans

2 January 2024

65

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart

2 January 2024

68

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease

2 January 2024

69

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

2 January 2024

70

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug

2 January 2024

73

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent

2 January 2024

80

1 reference

https://api.crossref.org/works/10.1177/107424840300800103

2 January 2024

Identifiers

0 references

1 reference